首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan.
【24h】

Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan.

机译:在患有2型糖尿病肾病的受试者中,脂联素与胰岛素抵抗呈正相关,并且与血管紧张素II 1型受体阻滞剂氯沙坦有关。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Plasma adiponectin concentration is inversely associated with renal function. There is little literature on adiponectin levels and regulation by anti-hypertensive medication with an angiotensin II type 1 receptor blocker (ARB), especially in subjects with type 2 diabetes in different stages of chronic kidney disease (CKD). METHODS: Eighty subjects with type 2 diabetic nephropathy were randomly divided into two groups: losarten group (n = 41) and amlodipine group (n = 39). Fasting blood was drawn to determine HbA1c, insulin and adiponectin levels. Insulin resistance was calculated using fasting glucose and insulin, expressed as HOMA-IR. For assessment of the relationship between adiponectin and other parameters, Pearson sample correlation coefficients were used. After stratification, ARB losartan (100 mg daily) was administered for a period of 6 months. RESULTS: There is a positive association between adiponectin and proteinuria, fasting insulin levels and HOMA-IR in both CKD stage 1-2 and stage 3-4. Baseline adiponectin levels were not related to baseline estimated glomerular filtration rate (eGFR). At baseline, the adiponectin concentration was high in all observed subjects, and after 3 and 6 months of treatment with losartan, adiponectin levels decreased in the losartan group as compared with the amlodipine group (P < 0.01). Also fasting insulin and HOMA-IR decreased during the 6-month follow-up compared with the control group (P < 0.01). CONCLUSION: Our results demonstrate that serum adiponectin levels in type 2 diabetic nephropathy are strongly positively associated with fasting insulin levels and insulin resistance. Declines in fasting insulin and HOMA-IR by losartan are accompanied by decreased adiponectin levels, might offer potential protection in humans. The paradoxical phenomenon merits further ascertainment in future studies.
机译:背景:血浆脂联素浓度与肾功能呈负相关。关于脂联素水平和抗高血压药物与血管紧张素II 1型受体阻滞剂(ARB)的调节的文献很少,尤其是在慢性肾脏病(CKD)不同阶段的2型糖尿病患者中。方法:将80名2型糖尿病肾病患者随机分为两组:氯沙坦组(n = 41)和氨氯地平组(n = 39)。空腹抽血以确定HbA1c,胰岛素和脂联素水平。使用空腹葡萄糖和胰岛素计算胰岛素抵抗,表示为HOMA-IR。为了评估脂联素与其他参数之间的关系,使用了Pearson样本相关系数。分层后,给予ARB氯沙坦(每天100毫克),为期6个月。结果:CKD 1-2期和3-4期脂联素与蛋白尿,空腹胰岛素水平和HOMA-IR呈正相关。基线脂联素水平与基线估计的肾小球滤过率(eGFR)无关。在基线时,所有观察到的受试者中脂联素浓度都很高,并且在与洛沙坦治疗后3个月和6个月后,与氨氯地平组相比,洛沙坦组的脂联素水平降低了(P <0.01)。与对照组相比,在6个月的随访期间,空腹胰岛素和HOMA-IR也降低了(P <0.01)。结论:我们的结果表明2型糖尿病肾病患者的血清脂联素水平与空腹胰岛素水平和胰岛素抵抗密切相关。氯沙坦使空腹胰岛素和HOMA-IR下降,并伴有脂联素水平降低,可能为人类提供潜在的保护。矛盾的现象值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号